Urinary Elimination of Bile Acid Glucuronides under Severe Cholestatic Situations: Contribution of Hepatic and Renal Glucuronidation Reactions

Canadian Journal of Gastroenterology & Hepatology
Martin PerreaultOlivier Barbier

Abstract

Biliary obstruction, a severe cholestatic complication, causes accumulation of toxic bile acids (BAs) in liver cells. Glucuronidation, catalyzed by UDP-glucuronosyltransferase (UGT) enzymes, detoxifies cholestatic BAs. Using liquid chromatography coupled to tandem mass spectrometry, 11 BA glucuronide (-G) species were quantified in prebiliary and postbiliary stenting serum and urine samples from 17 patients with biliary obstruction. Stenting caused glucuronide- and fluid-specific changes in BA-G levels and BA-G/BA metabolic ratios. In vitro glucuronidation assays with human liver and kidney microsomes revealed that even if renal enzymes generally displayed lower K M values, the two tissues shared similar glucuronidation capacities for BAs. By contrast, major differences between the two tissues were observed when four human BA-conjugating UGTs 1A3, 1A4, 2B4, and 2B7 were analyzed for mRNA and protein levels. Notably, the BA-24G producing UGT1A3 enzyme, abundant in the liver, was not detected in kidney microsomes. In conclusion, the circulating and urinary BA-G profiles are hugely impacted under severe cholestasis. The similar BA-glucuronidating abilities of hepatic and renal extracts suggest that both the liver and kidney may c...Continue Reading

References

May 1, 1985·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A StiehlM Senn
Apr 1, 1984·Gastroenterologia Japonica·H TakikawaY Seyama
Aug 18, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·A StiehlS Walker
Oct 21, 1999·The Journal of Steroid Biochemistry and Molecular Biology·W E GallA Radominska-Pandya
Jan 25, 2003·Annual Review of Biochemistry·David W Russell
Aug 9, 2003·Nucleic Acids Research·R G Rutledge, C Côté
Jun 25, 2005·Journal of Hepatology·Christiane Pauli-MagnusPeter J Meier
Sep 6, 2005·Pharmacogenetics and Genomics·Peter I MackenzieDaniel W Nebert
Jul 28, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mélanie VerreaultOlivier Barbier
May 16, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Akiko NakamuraTsuyoshi Yokoi
Feb 21, 2009·World Journal of Gastroenterology : WJG·Maria J MonteJose Vazquez-Tato
May 15, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Takeshi IzukawaTsuyoshi Yokoi
Nov 6, 2009·The Journal of Biological Chemistry·Jocelyn TrottierOlivier Barbier
Jun 29, 2010·Journal of Digestive Diseases·Gustav Paumgartner
Sep 11, 2010·Biopharmaceutics & Drug Disposition·Sophie L ReganB Kevin Park
Jun 13, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Martin PerreaultOlivier Barbier

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

Enzyme Kinetics
JMP Statistical Discovery
Sigma Plot

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.